(Q51965427)

English

Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses.

scientific article published on 31 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

author name string

Adriana Baz

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Kathy Buttigieg

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Weiguang Zeng

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Michael Rizkalla

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Penny Groves

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

language of work or name

0 references

publication date

31 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

26

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

21

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

2570-2579

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

More than one reason to rethink the use of peptides in vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Toll-like receptors: linking innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Lipid-based self-adjuvanting vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Granzymes at a glance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.03.022

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51965427&oldid=1368940766"